BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31301878)

  • 1. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
    Kwon MJ; Byeon S; Kang SY; Kim KM
    Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma.
    Akazawa Y; Saito T; Hayashi T; Yanai Y; Tsuyama S; Akaike K; Suehara Y; Takahashi F; Takamochi K; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
    Hum Pathol; 2018 Aug; 78():79-88. PubMed ID: 29751042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
    He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
    Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
    Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
    Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
    Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Primary Gastric Adenocarcinoma with Enteroblastic Differentiation(GAED)].
    Ochi F; Miyoshi T; Nishida M; Watanabe N; Ujiie K; Nakamura Y; Ito N; Takemura M; Yamaguchi A; Kakihara N; Ikawa O; Okano S; Taniguchi H
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2355-2357. PubMed ID: 33468959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological features of gastric adenocarcinoma with enteroblastic differentiation: a report of twelve cases].
    Li JZ; Huang HJ; Chen XY; Chen X
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):626-631. PubMed ID: 34078051
    [No Abstract]   [Full Text] [Related]  

  • 9. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of gastric adenocarcinoma with enteroblastic differentiation resected by endoscopic submucosal dissection.
    Kato T; Hikichi T; Nakamura J; Takasumi M; Hashimoto M; Kobashi R; Takagi T; Suzuki R; Sugimoto M; Sato Y; Okubo Y; Satake S; Oka Y; Yamada S; Kobayakawa M; Hashimoto Y; Ohira H
    Clin J Gastroenterol; 2021 Jun; 14(3):736-744. PubMed ID: 33629257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.
    Kumashiro Y; Yao T; Aishima S; Hirahashi M; Nishiyama K; Yamada T; Takayanagi R; Tsuneyoshi M
    Hum Pathol; 2007 Jun; 38(6):857-63. PubMed ID: 17320150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
    Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
    Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
    Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
    APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation.
    Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Murakami T; Ueyama H; Watanabe S; Nagahara A; Yao T
    Hum Pathol; 2019 Jun; 88():18-26. PubMed ID: 30946932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early gastric cancer involving a pure enteroblastic differentiation component that was curatively resected via endoscopic submucosal dissection.
    Ikezawa N; Tanaka S; Kaku H; Takao T; Morita Y; Toyonaga T; Komatsu M; Yokozaki H; Ito T; Kodama Y
    Clin J Gastroenterol; 2020 Aug; 13(4):512-516. PubMed ID: 32227292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
    Shiratsu K; Higuchi K; Nakayama J
    Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
    Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
    Virchows Arch; 2019 Mar; 474(3):315-324. PubMed ID: 30554333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.